102 related articles for article (PubMed ID: 2057420)
1. The in vivo effect of regional hyperthermia on dunning R3327 prostatic tumor.
Tucker RD; Loening SA; Landas S; Mardan AH; Ren ZY; Lubaroff DM
Prostate; 1991; 18(4):321-9. PubMed ID: 2057420
[TBL] [Abstract][Full Text] [Related]
2. Regional hyperthermia combined with high energy shock wave treatment on Dunning prostate tumors.
Ren ZY; Tucker R; Landas S; Lubaroff DM; Sparrow HK; Loening SA
J Lithotr Stone Dis; 1990 Jul; 2(3):211-9. PubMed ID: 10148921
[TBL] [Abstract][Full Text] [Related]
3. Magnetic fluid hyperthermia (MFH)reduces prostate cancer growth in the orthotopic Dunning R3327 rat model.
Johannsen M; Thiesen B; Jordan A; Taymoorian K; Gneveckow U; Waldöfner N; Scholz R; Koch M; Lein M; Jung K; Loening SA
Prostate; 2005 Aug; 64(3):283-92. PubMed ID: 15726645
[TBL] [Abstract][Full Text] [Related]
4. In vivo effects of high-intensity ultrasound on prostatic adenocarcinoma Dunning R3327.
Chapelon JY; Margonari J; Vernier F; Gorry F; Ecochard R; Gelet A
Cancer Res; 1992 Nov; 52(22):6353-7. PubMed ID: 1423282
[TBL] [Abstract][Full Text] [Related]
5. Synergistic interaction of ultrasonic shock waves and hyperthermia in the Dunning prostate tumor R3327-AT1.
Huber P; Peschke P; Brix G; Hahn EW; Lorenz A; Tiefenbacher U; Wannenmacher M; Debus J
Int J Cancer; 1999 Jul; 82(1):84-91. PubMed ID: 10360825
[TBL] [Abstract][Full Text] [Related]
6. Interaction of irradiation and microwave-induced hyperthermia in the Dunning R3327G prostatic adenocarcinoma model.
Gottlieb CF; Seibert GB; Block NL
Radiology; 1988 Oct; 169(1):243-7. PubMed ID: 3420266
[TBL] [Abstract][Full Text] [Related]
7. The effect of interstitial hyperthermia on the Dunning prostate tumor model.
Tucker RD; Loening SA; Landas S; Paulus JA; Ren ZY; Park JB
J Urol; 1992 Apr; 147(4):1129-33. PubMed ID: 1552609
[TBL] [Abstract][Full Text] [Related]
8. Effects of olfactory bulbectomy, melatonin, and/or pinealectomy on three sublines of the Dunning R3327 rat prostatic adenocarcinoma.
Toma JG; Amerongen HM; Hennes SC; O'Brien MG; McBlain WA; Buzzell GR
J Pineal Res; 1987; 4(3):321-38. PubMed ID: 3625464
[TBL] [Abstract][Full Text] [Related]
9. Focal laser interstitial thermotherapy (LITT) at 980 nm for prostate cancer: treatment feasibility in Dunning R3327-AT2 rat prostate tumour.
Colin P; Nevoux P; Marqa M; Auger F; Leroy X; Villers A; Puech P; Mordon S; Betrouni N
BJU Int; 2012 Feb; 109(3):452-8. PubMed ID: 21895930
[TBL] [Abstract][Full Text] [Related]
10. Differential sensitivity of three sublines of the rat Dunning prostate tumor system R3327 to radiation and/or local tumor hyperthermia.
Peschke P; Hahn EW; Wenz F; Lohr F; Braunschweig F; Wolber G; Zuna I; Wannenmacher M
Radiat Res; 1998 Oct; 150(4):423-30. PubMed ID: 9768856
[TBL] [Abstract][Full Text] [Related]
11. Antiestrogens do not counteract the inhibitory effect of estradiol-17 beta on the growth of the Dunning R3327 prostatic adenocarcinoma.
Landström M; Damber JE; Bergh A; Tomic R; Carlsson-Bostedt L; Stigbrand T
Prostate; 1988; 12(4):287-98. PubMed ID: 3393491
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-2-induced growth inhibition of prostatic adenocarcinoma (Dunning R3327) in rats.
Henriksson R; Widmark A; Bergh A; Damber JE
Urol Res; 1992; 20(3):189-91. PubMed ID: 1615579
[TBL] [Abstract][Full Text] [Related]
13. Heat shock protein response in a prostate tumor model to interstitial thermotherapy: implications for clinical treatment.
Paulus JA; Tucker RD; Flanagan SW; Moseley PL; Loening SA; Park JB
Prostate; 1993; 23(3):263-70. PubMed ID: 8234068
[TBL] [Abstract][Full Text] [Related]
14. Improved therapeutic response by distinct timing of multiple heat treatments during interstitial radiation in the Dunning R3327 prostate tumor model.
Peschke P; Heimburg S; Wolber G; Zuna I; Hahn EW
J Cancer Res Clin Oncol; 1998; 124(3-4):172-8. PubMed ID: 9619743
[TBL] [Abstract][Full Text] [Related]
15. Role of prolactin in modulating the effects of tamoxifen on growth of the Dunning R3327 rat prostate adenocarcinoma.
Sylvester PW; Ip MM
Prostate; 1987; 10(1):57-67. PubMed ID: 3822918
[TBL] [Abstract][Full Text] [Related]
16. Effect of the preestrogen 4-androstene-3,17-dion-19-al on the Dunning R3327 prostatic adenocarcinoma.
Marks TA; Petrow V
Cancer Res; 1983 Aug; 43(8):3687-90. PubMed ID: 6861138
[TBL] [Abstract][Full Text] [Related]
17. Estramustine potentiates the effects of irradiation on the Dunning (R3327) rat prostatic adenocarcinoma.
Widmark A; Damber JE; Bergh A; Henriksson R
Prostate; 1994; 24(2):79-83. PubMed ID: 8309847
[TBL] [Abstract][Full Text] [Related]
18. Effects of 6-methylene progesterone on growth, morphology, and blood flow of the Dunning R3327 prostatic adenocarcinoma.
Damber JE; Bergh A; Daehlin L; Petrow V; Landström M
Prostate; 1992; 20(3):187-97. PubMed ID: 1574466
[TBL] [Abstract][Full Text] [Related]
19. Beta-galactosidase as a marker of HSP70 promoter induction in Dunning R3327 prostate carcinoma cells.
Roigas J; Wallen ES; Loening SA; Moseley PL
Urol Res; 1997; 25(4):251-5. PubMed ID: 9286033
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonist RC-3095 on the growth of the androgen-independent Dunning R-3327-AT-1 rat prostate cancer.
Pinski J; Reile H; Halmos G; Groot K; Schally AV
Cancer Res; 1994 Jan; 54(1):169-74. PubMed ID: 7903203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
